Psychiatric co-morbidity, distress, and use of psycho-social services in adult glioma patients—a prospective study
- 35 Downloads
Distress impacts the daily life of glioma patients. This study explored its course over time and the usage of psychosocial care.
A consecutive sample of glioma patients completed the Hospital Anxiety and Depression Scale to assess distress levels at admission to the hospital (t1), before discharge (t2), after 3 months (t3), and after 6 months (t4). They were interviewed with the Structured Clinical Interview for DSM-IV to ascertain psychiatric disorders at t2. Psycho-oncological care in the hospital was determined with the Hospital Information System, and the use of outpatient treatment was evaluated with the Health Care Usage Questionnaire at t4. We compared the percentages of elevated distress, psychiatric co-morbidity, and care usage between men and women.
During the study period, 37 patients were enrolled. Nineteen percent of the patients were diagnosed with a psychiatric disorder. The percentages of patients with elevated distress were 56, 59, 39, and 40% at t1, t2, t3, and t4, respectively. Participants who did not survive the 6 months presented with higher levels of distress. In the hospital, 14% of those with elevated distress were visited by a psycho-oncologist. In the outpatient setting, 43% of those with elevated distress visited a neuro-psychiatrist, and 14% went to a psychotherapist. There was no evidence for an effect of gender on psychiatric co-morbidity, distress, or care use.
A significant proportion of glioma patients report elevated distress during the hospital stay and thereafter. Only a fraction of them receive mental health care.
KeywordsDepression Anxiety Glioma Glioblastoma Astrocytoma Patient-reported outcomes
Compliance with ethical standards
Conflict of interest
SS received a grant from Pfizer, the quality of life prize from Lilly, and lecture fees from Pfizer, Bristol-Myers Squibb, and Boehringer Ingelheim. These were unrelated to the study presented here. The other authors declare that they have no conflict of interest.
All procedures performed were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments. The study protocol was approved by the local ethics committee. All participants provided written informed consent.
- 1.Aaronson N, Ahmedzai S, Bergmann B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, de Haes JCJM, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F, for the EORTC Study Group on Quality of Life (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376CrossRefPubMedGoogle Scholar
- 3.Boele FW, van Uden-Kraan CF, Hilverda K, Reijneveld JC, Cleijne W, Klein M, Verdonck-de Leeuw IM (2016) Attitudes and preferences toward monitoring symptoms, distress, and quality of life in glioma patients and their informal caregivers. Support Care Cancer 24:3011–3022PubMedPubMedCentralGoogle Scholar
- 7.DAngelo C, Mirijello A, Leggio L, Ferrulli A, Carotenuto V, Icolaro N, Miceli A, D'Angelo V, Gasbarrini G, Addolorato G (2008) State and trait anxiety and depression in patients with primary brain tumors before and after surgery: 1-year longitudinal study. J Neurosurg 108:281–286CrossRefGoogle Scholar
- 10.Erharter A, Giesinger J, Kemmler G, Schauer-Maurer G, Stockhammer G, Muigg A, Hutterer M, Rumpold G, Sperner-Unterweger B, Holzner B (2010) Implementation of computer-based quality-of-life monitoring in brain tumor outpatients in routine clinical practice. J Pain Symptom Manag 39:219–229CrossRefGoogle Scholar
- 11.First M, Spitzer R, Gibbon M, Williams J (1997) Structured clinical interview for DSM-IV Axis I disorders (SCID-I), clinician version. American Psychiatric Press, Washington, DCGoogle Scholar
- 14.Glaesmer H, Brahler E, Martin A, Mewes R, Rief W (2008) Gender differences in subjective help seeking threshold and health care utilization: is there an interrelation between both features? Int J Psychol 43:438Google Scholar
- 17.Grassi L, Watson M, on behalf of the IPOS Federation of Psycho-Oncology Societies' co-authors (2012) Psychosocial care in cancer: an overview of psychosocial programmes and national cancer plans of countries within the International Federation of Psycho-Oncology Societies. Psycho-Oncology 21:1027–1033CrossRefPubMedGoogle Scholar
- 18.Hickmann AK, Nadji-Ohl M, Haug M, Hopf N, Ganslandt O, Giese A, Renovanz M (2016) Suicidal ideation, depression, and health-related quality of life in patients with benign and malignant brain tumors: a prospective observational study in 83 patients. Acta Neurochir 158:1669–1682CrossRefPubMedGoogle Scholar
- 26.Mehnert A, Brähler E, Faller H, Härter M, Keller M, Schulz H, Wegscheider K, Weis J, Boehncke A, Hund B, Reuter K, Richard M, Sehner S, Sommerfeldt S, Szalai C, Wittchen HU, Koch U (2014) Four-week prevalence of mental disorders in cancer patients across major tumor entitites. J Clin Oncol 32:3540–3546CrossRefPubMedGoogle Scholar
- 28.Mitchell AJ, Symonds P (2013) Implementation of distress screening by Cancer clinicians during routine clinical care. Part I. Focus on efficiency and acceptability of frontline screening. Psychooncology 22:91Google Scholar
- 31.Renovanz M, Hickmann A-K, Coburger J, Kohlmann K, Janko M, Reuter AK, Keric N, Gutenberg A, Nadji-Ohl M, König J, Singer S, Giese A, Hechtner M (2017) Assessing psychological and supportive care needs in Glioma patients – feasibility study on the use of the supportive care needs survey short form (SCNS-SF34-G) and the supportive care needs survey screening tool (SCNS-ST9) in clinical practice. Eur J Cancer Care. https://doi.org/10.1111/ecc.12598
- 38.Scaratti C, Leonardi M, Saladino A, Anghileri E, Broggi M, Lamperti E, Fariselli L, Ayadi R, Tringali G, Schiavolin S (2017) Needs of neuro-oncological patients and their caregivers during the hospitalization and after discharge: results from a longitudinal study. Support Care Cancer 25:2137–2145CrossRefPubMedGoogle Scholar
- 46.Velikova G, Coens C, Efficace F, Greimel E, Groenvold M, Johnson C, Singer S, van de Poll-Franse L, Young T, Bottomley A, on behalf of the EORTC Quality of Life Group (2012) Health-related quality of life in EORTC clinical trials - 30 years of progress from methodological developments to making a real impact on oncology practice. Eur J Cancer Suppl 10:141–149CrossRefGoogle Scholar
- 48.Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jonsson B, Olesen J, Allgulander C, Alonso J, Faravelli C, Fratiglioni L, Jennum P, Lieb R, Maercker A, van Os J, Preisig M, Salvador-Carulla L, Simon R, Steinhausen HC (2011) The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 21:655–679CrossRefPubMedGoogle Scholar